iShares $ Corp Bond ETF USD Dist (LQDA)
After hours:
| Previous close | 11.46 |
| Open | 11.57 |
| Bid | 11.60 x 800 |
| Ask | 11.65 x 600 |
| Day's range | 11.29 - 11.64 |
| 52-week range | 5.71 - 16.99 |
| Volume | |
| Avg. volume | 805,512 |
| Market cap | 888.692M |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.57 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 27.67 |
Simply Wall St.High Insider Ownership Marks These US Growth Companies For July 2024
As of July 2024, major U.S. stock indexes like the Dow Jones, S&P 500, and Nasdaq have been experiencing fluctuations, reflecting a mix of investor reactions to corporate earnings and economic indicators. In this context, examining growth companies with high insider ownership can offer valuable insights, as such ownership might suggest confidence from those who know the company best amidst current market volatilities.
Simply Wall St.High Insider Ownership Growth Companies On US Exchange For June 2024
As the U.S. markets continue to exhibit resilience, with tech stocks like Nvidia leading the charge and indices like the S&P 500 and Nasdaq achieving record closes, investors are keenly observing market dynamics. In such an environment, growth companies with high insider ownership can be particularly compelling, as substantial insider stakes often align management’s interests with those of shareholders, potentially enhancing trust and long-term value in times of economic optimism driven by...
GlobeNewswireLiquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) inhalation suspension MORRISVILLE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present seven posters related to its product pipeline at the 7th World Symposia of Pulmonary Hypertension (WSPH) taking place June 29 to July 1, 2024, in Barcelona,
